Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377221 · ClinicalTrials.gov registry record
Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability
A clinical trial of Rectal Health and Rectal Behaviors, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 896
- Enrollment target
- 2
- Study locations
NCT00377221 is a study of Rectal Health and Rectal Behaviors that has completed, run by University of California, Los Angeles. The registered enrollment target is 896 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT00377221, a study of Rectal Health and Rectal Behaviors, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 896 participants
- Enrollment target
- 2
- Study locations
Study Summary
Observational, cross-sectional, single-visit study of 896 men and women in Los Angeles, CA and Baltimore, MD including a computer-assisted interview focusing on the behavioral repertoire surrounding RAI, symptoms, and health seeking behaviors and a multidimensional assessment of behaviors, anorectal examination, and testing for sexually transmitted infections (STIs).
Conditions Studied
Study Locations (2)
California
- AIDS Research Alliance - Los Angeles
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 896 participants |
| Start Date | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377221
The ClinicalTrials.gov registry entry for NCT00377221 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 896 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Rectal Health appearing as the primary indexed condition, and to 0 interventions.
NCT00377221 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Maryland.
Frequently Asked Questions
What is clinical trial NCT00377221 about?
NCT00377221 is a clinical study titled "Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability". Observational, cross-sectional, single-visit study of 896 men and women in Los Angeles, CA and Baltimore, MD including a computer-assisted interview focusing on the behavioral repertoire surrounding RAI, symptoms, and health seeking behaviors and a multidimensional assessment of behaviors, anorectal...
What is the current status of trial NCT00377221?
This trial is currently completed. The enrollment target is 896 participants. The study started on 2006-09.
What conditions does trial NCT00377221 study?
This clinical trial studies the following conditions: Rectal Health, Rectal Behaviors, Anorectal Symptomatology.
Who is sponsoring clinical trial NCT00377221?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00377221 being conducted?
This trial has 2 study locations across California, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.